Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

502 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside.
Santoni M, Santini D, Massari F, Conti A, Iacovelli R, Burattini L, Tortora G, Falconi M, Montironi R, Cascinu S. Santoni M, et al. Cancer Metastasis Rev. 2014 Mar;33(1):321-31. doi: 10.1007/s10555-013-9453-5. Cancer Metastasis Rev. 2014. PMID: 24337954 Review.
The route to personalized medicine in bladder cancer: where do we stand?
Massari F, Ciccarese C, Santoni M, Brunelli M, Conti A, Modena A, Montironi R, Santini D, Cheng L, Martignoni G, Cascinu S, Tortora G. Massari F, et al. Among authors: santoni m. Target Oncol. 2015 Sep;10(3):325-36. doi: 10.1007/s11523-015-0357-x. Epub 2015 Jan 30. Target Oncol. 2015. PMID: 25634607 Review.
Bladder cancer: molecular determinants of personalized therapy.
Lopez-Beltran A, Santoni M, Massari F, Ciccarese C, Tortora G, Cheng L, Moch H, Scarpelli M, Reymundo C, Montironi R. Lopez-Beltran A, et al. Among authors: santoni m. Curr Drug Targets. 2015;16(2):115-24. doi: 10.2174/1389450116666150204115756. Curr Drug Targets. 2015. PMID: 25654736 Review.
Present and future of personalized medicine in adult genitourinary tumors.
Ciccarese C, Santoni M, Massari F, Cheng L, Lopez-Beltran A, Scarpelli M, Conti A, Tortora G, Cascinu S, Montironi R. Ciccarese C, et al. Among authors: santoni m. Future Oncol. 2015;11(9):1381-8. doi: 10.2217/fon.15.30. Future Oncol. 2015. PMID: 25952784 Review.
The immunocheckpoints in modern oncology: the next 15 years.
Massari F, Santoni M, Ciccarese C, Santini D. Massari F, et al. Among authors: santoni m. Expert Opin Biol Ther. 2015 Jul;15(7):917-21. doi: 10.1517/14712598.2015.1035251. Expert Opin Biol Ther. 2015. PMID: 26063384
502 results